News & Events
-
April 1, 2017
Challenges and Opportunities to Enhance Global Drug Development in Neonates
Smith AM, Davis JM. Challenges and Opportunities to Enhance Global Drug Development in Neonates. Current Opinion in Pediatrics. 2017 Apr; 29(2):149–52.
-
March 1, 2017
Tuberculosis Eradication versus Control
Schito M, Hanna D, Zumla A. Tuberculosis Eradication versus Control. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2017 Mar 1;56:10–3.
-
March 1, 2017
World TB Day 2017: Advances, Challenges and Opportunities in the “End-TB” Era
Petersen E, Maeurer M, Marais B, Migliori GB, Mwaba P, Ntoumi F, Vilaplana C, Kim K, Schito M, Zumla A. World TB Day 2017: Advances, Challenges and Opportunities in the “End-TB” Era. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2017 Mar;56:1–5.
-
March 1, 2017
Removing the Bottleneck in Whole Genome Sequencing of Mycobacterium Tuberculosis for Rapid Drug Resistance Analysis: A Call to Action
McNerney R, Clark TG, Campino S, Rodrigues C, Dolinger D, Smith L, Cabibbe AM, Dheda K, Schito M. Removing the Bottleneck in Whole Genome Sequencing of Mycobacterium Tuberculosis for Rapid Drug Resistance Analysis: A Call to Action. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2017 Mar;56:130–5.
-
February 1, 2017
Validity of Low-Contrast Letter Acuity as a Visual Performance Outcome Measure for Multiple Sclerosis
Balcer LJ, Raynowska J, Nolan R, Galetta SL, Kapoor R, Benedict R, Phillips G, LaRocca N, Hudson L, Rudick R, Multiple Sclerosis Outcome Assessments Consortium. Validity of Low-Contrast Letter Acuity as a Visual Performance Outcome Measure for Multiple Sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 2017 Feb 1;23(5):734–7.